Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4878076
Max Phase: Preclinical
Molecular Formula: C38H50N6O6
Molecular Weight: 686.85
Molecule Type: Unknown
Associated Items:
ID: ALA4878076
Max Phase: Preclinical
Molecular Formula: C38H50N6O6
Molecular Weight: 686.85
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN1CCCNC(=O)CC2(CCCCC2)CC(=O)NCCCN(C)CCCN2C(=O)c3ccc4c5c(ccc(c35)C2=O)C(=O)N(CCC1)C4=O
Standard InChI: InChI=1S/C38H50N6O6/c1-41-18-6-16-39-30(45)24-38(14-4-3-5-15-38)25-31(46)40-17-7-19-42(2)21-9-23-44-36(49)28-12-10-26-32-27(11-13-29(33(28)32)37(44)50)35(48)43(34(26)47)22-8-20-41/h10-13H,3-9,14-25H2,1-2H3,(H,39,45)(H,40,46)
Standard InChI Key: GQRCRRQQZOMLPW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 686.85 | Molecular Weight (Monoisotopic): 686.3792 | AlogP: 3.43 | #Rotatable Bonds: 0 |
Polar Surface Area: 139.44 | Molecular Species: BASE | HBA: 8 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 9.61 | CX LogP: 1.12 | CX LogD: -2.69 |
Aromatic Rings: 2 | Heavy Atoms: 50 | QED Weighted: 0.40 | Np Likeness Score: -0.05 |
1. Fukuda H, Sato S, Zou T, Higashi S, Takahashi O, Habu M, Sasaguri M, Tominaga K, Takenaka S, Takeuchi H.. (2021) Substituent effects of cyclic naphthalene diimide on G-quadruplex binding and the inhibition of cancer cell growth., 50 [PMID:34400300] [10.1016/j.bmcl.2021.128323] |
Source(1):